Papers
1
Total Citations
45
H-Index
1
About
Bai-Hui Shan is a pioneering researcher in the field of bionic drug delivery systems, with a primary focus on bioinspired microrobotics and cancer nanomedicine. Their most notable contribution is the development of a red blood cell-derived bionic microrobot capable of hierarchically adapting to five critical stages in systemic drug delivery, a breakthrough published in 2023 that has already garnered 45 citations. This work addresses one of the most formidable challenges in anticancer treatment: the complexity of diverse biological barriers that drug delivery systems must sequentially overcome to reach cellular and subcellular targets. By engineering a microrobot that mimics the natural adaptability of red blood cells, Shan has created a platform that can navigate the bloodstream, evade immune clearance, extravasate into tumor tissue, penetrate cellular membranes, and release therapeutic payloads precisely at the intended site. This hierarchical adaptation strategy represents a paradigm shift in how researchers approach systemic drug delivery, offering a potential solution to the long-standing problem of poor tumour-targeting efficiency. Shan’s work stands at the intersection of robotics, materials science, and oncology, promising to transform the therapeutic landscape for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1